Drug Profile

Clomipramine/sildenafil - CTC Bio

Alternative Names: CDFR-0812

Latest Information Update: 09 Oct 2025

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator CTCBIO
Class Erectile dysfunction therapies; Small molecules
Mechanism of Action Adrenergic uptake inhibitors; Serotonin uptake inhibitors; Type 5 cyclic nucleotide phosphodiesterase inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Phase III Premature ejaculation

Most Recent Events

26 Apr 2025 Efficacy and adverse events data from a phase III trial in Premature ejaculation presented at the 120th Annual Meeting of the American Urological Association (AUA-2025)
31 Oct 2019 Phase-III clinical trials in Premature ejaculation in South Korea (PO)
05 Sep 2018 Discontinued - Phase-II for Premature ejaculation in South Korea (PO)

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com